Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Burylo AM"'
Autor:
de Weger VA; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Vermunt MAC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Stuurman FE; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Burylo AM; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Damoiseaux D; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Hendrikx JJMA; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sawicki E; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Modra Pharmaceuticals BV, Amsterdam, The Netherlands., Moes JJ; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, The Netherlands., Nuijen B; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Rosing H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mergui-Roelvink M; Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Modra Pharmaceuticals BV, Amsterdam, The Netherlands.; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Marchetti S; Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2021 Jun; Vol. 10 (6), pp. 607-621. Date of Electronic Publication: 2020 Oct 05.
Autor:
de Vries Schultink AHM; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands. ah.d.vriesschultink@nki.nl., Boekhout AH; Division of Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands., Gietema JA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Burylo AM; Division of Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands., Dorlo TPC; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands., van Hasselt JGC; Division of Systems Biomedicine and Pharmacology, Leiden Academic Centre for Drug Research, Leiden University, Einsteinweg 55, 2333 CC, Leiden, The Netherlands., Schellens JHM; Division of Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology & Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek - The Netherlands Cancer Institute, Louwesweg 6, 1066 EC, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, 3508 GA, Utrecht, The Netherlands.
Publikováno v:
Journal of pharmacokinetics and pharmacodynamics [J Pharmacokinet Pharmacodyn] 2018 Jun; Vol. 45 (3), pp. 431-442. Date of Electronic Publication: 2018 Feb 10.
Autor:
Burylo AM; Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Weger VA; Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Stuurman FE; Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Schellens JHM; Division of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2017 Dec; Vol. 117 (12), pp. 2356-2368. Date of Electronic Publication: 2017 Dec 06.
Autor:
de Jong C; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands., Sanders S; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands., Creemers GJ; Department of Internal Medicine, Catharina Hospital, Eindhoven, The Netherlands., Burylo AM; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Taks M; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands., Schellens JHM; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Faculty of Science, Utrecht Institute of Pharmaceutical Sciences (UIPS), Division of Clinical Pharmacology and Pharmaco-epidemiology, Utrecht University, Utrecht, The Netherlands., Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2017 Sep; Vol. 83 (9), pp. 2120-2122. Date of Electronic Publication: 2017 May 31.
Autor:
Jacobs BA; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Deenen MJ; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Pluim D; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Hasselt JG; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Krähenbühl MD; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Geel RM; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Vries N; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Rosing H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Meulendijks D; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Burylo AM; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Cats A; Department of Gastroenterology & Hepatology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Huitema AD; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schellens JH; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Publikováno v:
British journal of clinical pharmacology [Br J Clin Pharmacol] 2016 Sep; Vol. 82 (3), pp. 706-16. Date of Electronic Publication: 2016 Jun 03.
Autor:
Pluim D; Division of Molecular Pathology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Jacobs BA, Deenen MJ, Ruijter AE, van Geel RM, Burylo AM, Meulendijks D, Beijnen JH, Schellens JH
Publikováno v:
Bioanalysis [Bioanalysis] 2015; Vol. 7 (5), pp. 519-29.
Autor:
Deenen MJ; Division of Clinical Pharmacology, Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Tol J, Burylo AM, Doodeman VD, de Boer A, Vincent A, Guchelaar HJ, Smits PH, Beijnen JH, Punt CJ, Schellens JH, Cats A
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2011 May 15; Vol. 17 (10), pp. 3455-68. Date of Electronic Publication: 2011 Apr 15.